BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19800575)

  • 1. A lymphotoxin-driven pathway to hepatocellular carcinoma.
    Haybaeck J; Zeller N; Wolf MJ; Weber A; Wagner U; Kurrer MO; Bremer J; Iezzi G; Graf R; Clavien PA; Thimme R; Blum H; Nedospasov SA; Zatloukal K; Ramzan M; Ciesek S; Pietschmann T; Marche PN; Karin M; Kopf M; Browning JL; Aguzzi A; Heikenwalder M
    Cancer Cell; 2009 Oct; 16(4):295-308. PubMed ID: 19800575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxins: new targets for hepatocellular carcinoma.
    Villanueva A; Savic R; Llovet JM
    Cancer Cell; 2009 Oct; 16(4):272-3. PubMed ID: 19800570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.
    Giles DA; Zahner S; Krause P; Van Der Gracht E; Riffelmacher T; Morris V; Tumanov A; Kronenberg M
    Front Immunol; 2018; 9():2585. PubMed ID: 30524422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis.
    Seleznik GM; Reding T; Romrig F; Saito Y; Mildner A; Segerer S; Sun LK; Regenass S; Lech M; Anders HJ; McHugh D; Kumagi T; Hiasa Y; Lackner C; Haybaeck J; Angst E; Perren A; Balmer ML; Slack E; MacPherson A; Manz MG; Weber A; Browning JL; Arkan MC; Rülicke T; Aguzzi A; Prinz M; Graf R; Heikenwalder M
    Gastroenterology; 2012 Nov; 143(5):1361-1374. PubMed ID: 22863765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated thymic atrophy as a result of elevated homeostatic expression of the genes encoded by the TNF/lymphotoxin cytokine locus.
    Liepinsh DJ; Kruglov AA; Galimov AR; Shakhov AN; Shebzukhov YV; Kuchmiy AA; Grivennikov SI; Tumanov AV; Drutskaya MS; Feigenbaum L; Kuprash DV; Nedospasov SA
    Eur J Immunol; 2009 Oct; 39(10):2906-15. PubMed ID: 19735075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis.
    Simonin Y; Vegna S; Akkari L; Grégoire D; Antoine E; Piette J; Floc'h N; Lassus P; Yu GY; Rosenberg AR; Karin M; Durantel D; Hibner U
    PLoS Pathog; 2013 Mar; 9(3):e1003234. PubMed ID: 23555249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
    Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
    Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin β receptor signalling executes
    Mejías-Luque R; Zöller J; Anderl F; Loew-Gil E; Vieth M; Adler T; Engler DB; Urban S; Browning JL; Müller A; Gerhard M; Heikenwalder M
    Gut; 2017 Aug; 66(8):1369-1381. PubMed ID: 27196595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
    Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients.
    Chen Y; Zhang W; Cheng M; Hao X; Wei H; Sun R; Tian Z
    Viruses; 2024 May; 16(5):. PubMed ID: 38793619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection.
    Banks TA; Rickert S; Benedict CA; Ma L; Ko M; Meier J; Ha W; Schneider K; Granger SW; Turovskaya O; Elewaut D; Otero D; French AR; Henry SC; Hamilton JD; Scheu S; Pfeffer K; Ware CF
    J Immunol; 2005 Jun; 174(11):7217-25. PubMed ID: 15905567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.
    Liang Y; Yang K; Guo J; Wroblewska J; Fu YX; Peng H
    Sci Rep; 2015 May; 5():10406. PubMed ID: 25993659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postgestational lymphotoxin/lymphotoxin beta receptor interactions are essential for the presence of intestinal B lymphocytes.
    Newberry RD; McDonough JS; McDonald KG; Lorenz RG
    J Immunol; 2002 May; 168(10):4988-97. PubMed ID: 11994450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
    Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
    J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.